Jamp-Ferrous Fumarate Suspension
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Fumarate ferreux | 20 mg | Not calculated |
Non-medicinal ingredients
Glycérine, Caramel, d-Sorbitol, Saveur de cerise, Parahydroxybenzoate de méthyle, Carraghénine, Eau purifiée, Sucrose, Cyclamate de sodium, (p)-hydroxybenzoate de propyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 5 mL | 1 Tous les jours |
| Enfants | maximum: 18 years | 2 mL | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency. Helps to prevent iron deficiency anemia. Source of mineral, a factor in the maintenance of good health. Source of mineral, a factor in normal growthand development. Source of mineral to support biological functions which play a key role in the maintenance of good health. Maintains/supports good health. Contributes to maintaining general health. For maintaining general health. A factor in normal growth and development. Mineral supplement. Helps to prevent iron deficiency anemia and associated tiredness and fatigue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- JAMP Ferrous Fumarate Suspension
- Licence holder
- JAMP Pharma Corporation
- NPN or DIN-HM
- 80029822
- Status
- Active licence
- Licence date
- 23 February 2012
- Revision date
- 1 November 2024
- Form
- Suspension
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80029822
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Jamp-Ferrous Fumarate Suspension”, https://compoatlas.com/en/supplements/canada/80029822-jamp-ferrous-fumarate-suspension, updated 1 November 2024.